Skip to main content

Main menu

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • JRheum Supplements
  • Services

User menu

  • My Cart
  • Log In

Search

  • Advanced search
The Journal of Rheumatology
  • JRheum Supplements
  • Services
  • My Cart
  • Log In
The Journal of Rheumatology

Advanced Search

  • Home
  • Content
    • First Release
    • Current
    • Archives
    • Collections
    • Audiovisual Rheum
    • COVID-19 and Rheumatology
  • Resources
    • Guide for Authors
    • Submit Manuscript
    • Payment
    • Reviewers
    • Advertisers
    • Classified Ads
    • Reprints and Translations
    • Permissions
    • Meetings
    • FAQ
    • Policies
  • Subscribers
    • Subscription Information
    • Purchase Subscription
    • Your Account
    • Terms and Conditions
  • About Us
    • About Us
    • Editorial Board
    • Letter from the Editor
    • Duncan A. Gordon Award
    • Privacy/GDPR Policy
    • Accessibility
  • Contact Us
  • Follow jrheum on Twitter
  • Visit jrheum on Facebook
  • Follow jrheum on LinkedIn
  • Follow jrheum on YouTube
  • Follow jrheum on Instagram
  • Follow jrheum on RSS
Research ArticleArticle

Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease

Han Wang, Han-Xiong Liu, Yin-Li Wang, Xiu-Qiong Yu, Xian-Xiang Chen and Lin Cai
The Journal of Rheumatology March 2014, 41 (3) 495-500; DOI: https://doi.org/10.3899/jrheum.130346
Han Wang
From the Cardiovascular Disease Research Institute, The Third People’s Hospital of Chengdu, The Second Affiliated Chengdu Clinical College of Chongqing Medical University, Chengdu, Sichuan; and the Department of Surgery, People’s Hospital of Hubei University of Medicine, Shiyan, Hubei, China.
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Han-Xiong Liu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yin-Li Wang
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xiu-Qiong Yu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Xian-Xiang Chen
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wh7967@hotmail.com
Lin Cai
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: wh7967@hotmail.com
  • Article
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters
PreviousNext
Loading

Article Figures & Data

Tables

    • View popup
    Table 1.

    Clinical features of patients with dermatomyositis and controls. Data are mean ± SD unless otherwise indicated.

    Clinical FeaturesPatients, n = 51Controls, n = 51
    Age, yrs44.06 ± 11.8044.41 ± 10.60
    Female, %84.3184.31
    Duration, mos (range)8 (0.3, 48)—
    DAS score (range)10 (5, 17)—
    Muscle weakness, %100—
    Myalgia, %28.41—
    Polyarthralgia, %35.29—
    Heliotrope rash, %64.71—
    Gottron sign, %60.78—
    Shawl sign, %17.65—
    Raynaud phenomenon, %7.84—
    Lung involvement, %52.940
    Systolic BP, mmHg117.61 ± 11.57118.67 ± 10.03
    Diastolic BP, mmHg72.14 ± 12.9374.76 ± 7.27
    Heart rate, beats/min81.35 ± 6.7480.10 ± 4.13
    Triglyceride, mmol/l1.68 ± 0.771.36 ± 0.79*
    Total cholesterol, mmol/l4.79 ± 1.234.77 ± 0.70
    LDL cholesterol, mmol/l2.85 ± 1.212.71 ± 0.66
    HDL cholesterol, mmol/l1.44 ± 0.451.54 ± 0.34
    Serum uric acid, umol/l306.49 ± 95.38330.20 ± 93.52
    Fasting plasma glucose, mmol/l4.78 ± 0.794.84 ± 0.67
    ANA-positive, %84.310
    Anti-Jo1 antibody-positive, %9.800
    Medications, %
      Glucocorticoid94.110
      Methotrexate25.490
      Azathioprine3.920
      Cyclophosphamide21.570
      Hydroxychloroquine58.820
      IVIG00
      Biologics00
    • p < 0.05. DAS: Disease Activity Score; BP: blood pressure; LDL: low-density lipoprotein; HDL: high-density lipoprotein; IVIG: intravenous immunoglobulin; ANA: antinuclear antibody.

    • View popup
    Table 2.

    Echocardiographic and Doppler variables in patients with dermatomyositis and controls. Data are mean ± SD unless otherwise indicated.

    VariablePatients, n = 51Controls, n = 51p
    Left ventricular (LV) diameter, mm44.57 ± 4.3645.24 ± 3.22NS
    Left atrium diameter, mm30.39 ± 3.7229.51 ± 2.80NS
    Interventricular septum thickness, mm (range)9 (8, 10)9 (8, 10)NS
    Posterior wall thickness, mm (range)9 (8, 10)9 (8, 9)NS
    Aortic root diameter, mm (range)28 (26, 29)27 (26, 28)NS
    Ascending aorta diameter, mm (range)28 (27, 31)27 (26, 28)NS
    Main pulmonary artery diameter, mm (range)20 (19, 22)18 (17, 20)NS
    LV end-diastolic dimension, mm (range)45 (43, 47)45 (43, 48)NS
    LV end-systolic dimension, mm (range)28 (26, 30)28 (27, 30)NS
    LV end-diastolic volume, ml (range)92 (83, 104)93 (83, 106)NS
    LV end-systolic volume, ml30 (25, 34)30 (26, 35)NS
    Peak of early diastolic flow velocity (E), m/s0.72 ± 0.190.79 ± 0.16NS
    Peak of late diastolic flow velocity (A), m/s0.77 ± 0.180.67 ± 0.13< 0.05
    E/A ratio0.97 ± 0.331.20 ± 0.28< 0.001
    Mitral annular early diastolic velocity (Em), cm/s7.78 ± 2.909.32 ± 2.10< 0.05
    Mitral annular late diastolic velocity (Am), cm/s (range)8 (7, 9)7.3 (6.8, 9.2)NS
    Em/Am ratio (range)0.89 (0.64, 1.22)1.18 (1.04, 1.29)< 0.01
    E/Em ratio9.92 ± 2.828.67 ± 1.92< 0.05
    Deceleration time of flow velocity in early diastole (DT), ms231.75 ± 40.60208.20 ± 26.30< 0.01
    Isovolumic relaxation time, ms81.06 ± 19.3177.41 ± 11.32NS
    LV stroke volume, ml61.16 ± 12.2165.35 ± 10.830.069
    LV ejection fraction, %66.45 ± 6.8168.20 ± 4.110.120
    LV fractional shortening, % (range)38 (34, 40)38 (36, 41)0.284
    • NS: not significant (p > 0.05).

    • View popup
    Table 3.

    Correlation of left ventricular diastolic function variables and duration/DAS score in patients with dermatomyositis (DM).

    VariablesDM DurationDAS
    rprp
    Peak of early diastolic flow velocity (E)−0.2470.080−0.1800.206
    Peak of late diastolic flow velocity (A)0.3730.0070.0030.981
    E/A ratio−0.4670.001−0.2290.106
    Mitral annular early diastolic velocity (Em)−0.474< 0.001−0.1220.395
    Mitral annular late diastolic velocity (Am)0.0450.7560.1110.437
    Em/Am ratio−0.476< 0.001−0.2080.143
    E/Em0.3200.0220.0090.950
    DT of flow velocity in early diastole0.474< 0.0010.2130.133
    Isovolumic relaxation time0.2610.0650.2220.117
    • DAS: Disease Activity Score; DT: deceleration time.

    • View popup
    Table 4.

    The association between E/Em and disease duration in linear regression models.

    BSEβtp
    Model 1
      Constant6.9221.551—4.4640.000
      Age0.0460.0340.1931.3450.185
      Sex0.4481.0710.0580.4180.678
      Disease duration0.0910.0410.3182.2460.029
    Model 2
      Constant15.56.870—2.2560.029
      Age0.0550.0370.2311.4890.144
      Sex0.8851.1330.1150.7820.439
      Disease duration0.1310.0510.4572.5750.014
    DAS0.0410.1460.0420.2800.780
    Heart rate−0.1130.063−0.270−1.7980.079
    Fasting plasma glucose−0.3580.544−0.100−0.6580.514
    Systolic BP0.0030.0460.0110.0570.955
    Diastolic BP0.0100.0440.0460.2250.823
    • E/Em: early diastolic flow velocity/mitral annular early diastolic velocity; DAS: Disease Activity Score; BP: blood pressure; B: regression coefficient; SE: standard error.

PreviousNext
Back to top

In this issue

The Journal of Rheumatology
Vol. 41, Issue 3
1 Mar 2014
  • Table of Contents
  • Table of Contents (PDF)
  • Index by Author
  • Editorial Board (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about The Journal of Rheumatology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease
(Your Name) has forwarded a page to you from The Journal of Rheumatology
(Your Name) thought you would like to see this page from the The Journal of Rheumatology web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease
Han Wang, Han-Xiong Liu, Yin-Li Wang, Xiu-Qiong Yu, Xian-Xiang Chen, Lin Cai
The Journal of Rheumatology Mar 2014, 41 (3) 495-500; DOI: 10.3899/jrheum.130346

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

 Request Permissions

Share
Left Ventricular Diastolic Dysfunction in Patients with Dermatomyositis Without Clinically Evident Cardiovascular Disease
Han Wang, Han-Xiong Liu, Yin-Li Wang, Xiu-Qiong Yu, Xian-Xiang Chen, Lin Cai
The Journal of Rheumatology Mar 2014, 41 (3) 495-500; DOI: 10.3899/jrheum.130346
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • MATERIALS AND METHODS
    • RESULTS
    • DISCUSSION
    • Acknowledgment
    • Footnotes
    • REFERENCES
  • Figures & Data
  • References
  • Info & Metrics
  • PDF
  • eLetters

Keywords

DERMATOMYOSITIS
DIASTOLIC DYSFUNCTION
ECHOCARDIOGRAPHY

Related Articles

Cited By...

More in this TOC Section

  • Vasculitis: What Have We Learned in the Last 50 Years?
  • Demographic, Lifestyle, and Serologic Risk Factors for Rheumatoid Arthritis (RA)–associated Bronchiectasis: Role of RA-related Autoantibodies
  • Baseline Disease Activity Predicts Achievement of cDAPSA Treatment Targets With Apremilast: Phase III Results in DMARD-naïve Patients With Psoriatic Arthritis
Show more Article

Similar Articles

Keywords

  • DERMATOMYOSITIS
  • DIASTOLIC DYSFUNCTION
  • echocardiography

Content

  • First Release
  • Current
  • Archives
  • Collections
  • Audiovisual Rheum
  • COVID-19 and Rheumatology

Resources

  • Guide for Authors
  • Submit Manuscript
  • Author Payment
  • Reviewers
  • Advertisers
  • Classified Ads
  • Reprints and Translations
  • Permissions
  • Meetings
  • FAQ
  • Policies

Subscribers

  • Subscription Information
  • Purchase Subscription
  • Your Account
  • Terms and Conditions

More

  • About Us
  • Contact Us
  • My Alerts
  • My Folders
  • Privacy/GDPR Policy
  • RSS Feeds
The Journal of Rheumatology
The content of this site is intended for health care professionals.
Copyright © 2022 by The Journal of Rheumatology Publishing Co. Ltd.
Print ISSN: 0315-162X; Online ISSN: 1499-2752
Powered by HighWire